Capecitabine 500 mg / 1 Tablet 120 Tablet, Film Coated
Reference details for licensed healthcare facility review and verification.
| NDC 11 | 16729-0073-29 |
|---|---|
| Product NDC | 16729-0073 |
| Generic Drug Name | Capecitabine |
| Brand Name | Capecitabine |
| Manufacturer | Accord Healthcare Inc. |
| Strength | 500 mg / 1 |
| Dosage Form | Tablet |
| Drug Type | Oral |
| Package Quantity | 120 Tablet, Film Coated |
| Package Description | 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16729-073-29) |
| Active Ingredients | Capecitabine |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Capecitabine 500 mg / 1 Tablet is tracked under NDC 16729-0073-29 and rolls up into product family 16729-0073. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.
- Package configuration: 120 Tablet, Film Coated.
- Manufacturer: Accord Healthcare Inc..
- Dosage form: Tablet.
- Family size: 1 indexed presentation.
Click a tag to refine the catalog view around this product reference.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Potential alternatives with matching presentation
Open the comparison hub or review package-level listings from 15 product-NDC families with matching normalized presentation details. Review each product detail page before treating any item as a true alternative.
View Potential Alternative Hubcapecitabine 500 mg / 1 Tablet 120 Tablet, Film Coated Bottle15 package-level listings in the comparison hub.Sample package-level pages in this comparison set
Drug Shortage Information
Public sources confirm capecitabine has been included in FDA oncology shortage materials, with additional provider-facing context from Vizient on the broader oncology supply disruption.
Drug Shortage Index family
View Capecitabine in the Drug Shortage IndexCompare related NDC-level product references and family-level shortage context for Capecitabine.This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Capecitabine 500 mg / 1 Tablet 120 Tablet, Film Coated, NDC 16729-0073-29, is a Accord Healthcare Inc. 500 mg / 1 tablet presentation packaged as 120 Tablet, Film Coated. Current public shortage information is available for this product reference.
NDC search formats
- Canonical NDC 11: 16729-0073-29
- Digits-only NDC 11: 16729007329
- Possible 10-digit display format: 16729-073-29 (1672907329)
Helpful product links
- Search by brand name: Capecitabine
- NDC 11: 16729-0073-29
- Product family NDC: 16729-0073
- VA classification code: AN300
- VA classification code description: ANTINEOPLASTICS,ANTIMETABOLITES
- CMOP ID: C0796
- VUID: 4013202